Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection

Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection

US Patent 11058779 · Granted Jul 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies that bind the spike protein of SARS-CoV-22025
Orchestrated intelligent supply chain optimizer2025
Compositions and methods of mRNA vaccines against novel coronavirus infection2025
Orchestrated intelligent supply chain optimizer2024
Recombinant influenza viruses and constructs and uses thereof2024
Peptide docking vehicle for targeted nucleic acid delivery2024
Peptide docking vehicle for targeted nucleic acid delivery2024
Composition and method of mRNA vaccines against novel coronavirus infection2024
Composition and methods of RNAi prophylactics and therapeutics for treatment of 2024
Composition and methods of RNAi prophylactics and therapeutics for treatment of 2024
Composition and methods of RNAi prophylactics and therapeutics for treatment of 2024
Composition and methods of RNAi prophylactics and therapeutics for treatment of 2024